• Poster

Lapatinib Plus Capecitabine Versus Capecitabine Alone for ErbB2-Positive Metastatic Breast Cancer: Quality-of-Life Assessment

Citation

Zhou, X., Segreti, A., Cella, D., Cameron, D., Geyer, C., Amonkar, M. M., ... Walker, M. D. (2008, April). Lapatinib Plus Capecitabine Versus Capecitabine Alone for ErbB2-Positive Metastatic Breast Cancer: Quality-of-Life Assessment. Presented at 6th European Breast Cancer Conference, .

Abstract